高级检索
当前位置: 首页 > 详情页

Generalizable MRI-based Nasopharyngeal Carcinoma Delineation: Bridging Gaps across Multiple Centers and Raters with Active Learning

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital& Institute. Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu [2]School of Mechanical and Electrical Engineering, University of Electronic Science and Technology of China [3]Department of Systems Hub, Hong Kong University of Science and Technology (Guangzhou) [4]Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou [5]Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei,Anhui [6]Cancer center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu [7]Radiotherapy Physics & Technology Center, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China [8]The Shanghai AI Laboratory, Shanghai [9]The SenseTime Research, Shanghai
出处:
ISSN:

关键词: Nasopharyngeal carcinoma Deep learning Segmentation magnetic resonance

摘要:
To develop a deep learning (DL) method exploiting active learning and source-free domain adaptation for gross tumor volume (GTV) delineation in nasopharyngeal carcinoma (NPC), addressing the variability and inaccuracy when deploying segmentation models in multi-center and multi-rater settings.1057 MRI scans of NPC patients from five hospitals were retrospectively collected and annotated by experts from the same medical group with consensus for multi-center adaptation evaluation. One dataset was used for model development (source domain), with the remaining four for adaptation testing (target domains). Meanwhile, another 170 NPC patients with annotations delineated by four independent experts were built for multi-rater adaptation evaluation. We evaluated the pre-trained model's migration ability to the four multi-center and four multi-rater target domains. Dice similarity coefficient (DSC), 95% Hausdorff distance (HD95) and other metrics were used for quantitative evaluations.In the adaptation of dataset5 to other datasets, our source-free active learning adaptation method only requires limited labeled target samples (only 20%) to achieve a median DSC ranging from 0.70 to 0.86 and a median HD95 ranging from 3.16mm to 7.21mm for four target centers, and 0.78 to 0.85 and 3.64mm to 6.00mm for four multi-rater datasets. For DSC, our results for three of four multi-center datasets and all multi-rater datasets showed no statistical difference compared to the fully supervised U-Net model (P-values > 0.05) and significantly surpassed comparison models for three multi-center datasets and all multi-rater datasets (P-values < 0.05). Clinical assessment showed that our method-generated delineations can be used both in multi-center and multi-rater scenarios after minor refinement (revision ratio < 10% and median time < 2 minutes).The proposed method effectively minimizes domain gaps and delivers encouraging performance compared with fully supervised learning models with limited labeled training samples, offering a promising and practical solution for accurate and generalizable GTV segmentation in NPC.Copyright © 2024. Published by Elsevier Inc.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
第一作者:
第一作者机构: [1]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital& Institute. Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu [2]School of Mechanical and Electrical Engineering, University of Electronic Science and Technology of China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52808 今日访问量:2 总访问量:4561 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号